301 related articles for article (PubMed ID: 16538171)
21. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
22. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck.
Li G; Liu Z; Sturgis EM; Shi Q; Chamberlain RM; Spitz MR; Wei Q
Carcinogenesis; 2005 Sep; 26(9):1596-602. PubMed ID: 15878916
[TBL] [Abstract][Full Text] [Related]
23. Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer.
Kim EJ; Jeong P; Quan C; Kim J; Bae SC; Yoon SJ; Kang JW; Lee SC; Jun Wee J; Kim WJ
Urology; 2005 Jan; 65(1):70-5. PubMed ID: 15667866
[TBL] [Abstract][Full Text] [Related]
24. DNA polymorphisms in exon 1 and promoter of the CDH1 gene and relevant risk of transitional cell carcinoma of the urinary bladder.
Ma X; Xu H; Zheng T; Li HZ; Shi TP; Wang BJ; Ju ZH; Wang C; Zhang GX; Zhang X
BJU Int; 2008 Aug; 102(5):633-6. PubMed ID: 18384629
[TBL] [Abstract][Full Text] [Related]
25. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V
BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285
[TBL] [Abstract][Full Text] [Related]
26. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.
Kataoka N; Cai Q; Wen W; Shu XO; Jin F; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1148-52. PubMed ID: 16775174
[TBL] [Abstract][Full Text] [Related]
27. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer.
Zhang X; Miao X; Tan W; Ning B; Liu Z; Hong Y; Song W; Guo Y; Zhang X; Shen Y; Qiang B; Kadlubar FF; Lin D
Gastroenterology; 2005 Aug; 129(2):565-76. PubMed ID: 16083713
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population.
Wang LH; Ting SC; Chen CH; Tsai CC; Lung O; Liu TC; Lee CW; Wang YY; Tsai CL; Lin YC
J Oral Pathol Med; 2010 Feb; 39(2):155-61. PubMed ID: 20359312
[TBL] [Abstract][Full Text] [Related]
29. A polymorphism in the APE1 gene promoter is associated with lung cancer risk.
Lo YL; Jou YS; Hsiao CF; Chang GC; Tsai YH; Su WC; Chen KY; Chen YM; Huang MS; Hu CY; Chen CJ; Hsiung CA
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):223-9. PubMed ID: 19124501
[TBL] [Abstract][Full Text] [Related]
30. Caspase 9 promoter polymorphisms and risk of primary lung cancer.
Park JY; Park JM; Jang JS; Choi JE; Kim KM; Cha SI; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Lee JT; Jung TH
Hum Mol Genet; 2006 Jun; 15(12):1963-71. PubMed ID: 16687442
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.
Yang H; Dinney CP; Ye Y; Zhu Y; Grossman HB; Wu X
Cancer Res; 2008 Apr; 68(7):2530-7. PubMed ID: 18381463
[TBL] [Abstract][Full Text] [Related]
32. Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition.
Yang H; Gu J; Lin X; Grossman HB; Ye Y; Dinney CP; Wu X
Clin Cancer Res; 2008 Apr; 14(7):2236-44. PubMed ID: 18381966
[TBL] [Abstract][Full Text] [Related]
33. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
[TBL] [Abstract][Full Text] [Related]
34. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma.
Li G; Sturgis EM; Wang LE; Chamberlain RM; Spitz MR; El-Naggar AK; Hong WK; Wei Q
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3996-4002. PubMed ID: 15217930
[TBL] [Abstract][Full Text] [Related]
35. Possible correlation between polymorphism in the tumor necrosis factor-beta gene and the clinicopathological features of bladder cancer in Japanese patients.
Nonomura N; Tokizane T; Nakayama M; Inoue H; Nishimura K; Muramatsu M; Okuyama A
Int J Urol; 2006 Jul; 13(7):971-6. PubMed ID: 16882065
[TBL] [Abstract][Full Text] [Related]
36. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.
Zhu Y; Lai M; Yang H; Lin J; Huang M; Grossman HB; Dinney CP; Wu X
Carcinogenesis; 2007 Mar; 28(3):698-703. PubMed ID: 17052994
[TBL] [Abstract][Full Text] [Related]
37. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
[TBL] [Abstract][Full Text] [Related]
38. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for urinary bladder cancer in North India.
Gangwar R; Mandhani A; Mittal RD
Surgery; 2011 Jan; 149(1):126-34. PubMed ID: 20627335
[TBL] [Abstract][Full Text] [Related]
39. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F
Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721
[TBL] [Abstract][Full Text] [Related]
40. Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India.
Bid HK; Manchanda PK; Mittal RD
Urology; 2006 May; 67(5):1099-104. PubMed ID: 16698387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
